The 2026 Healthtech Messaging Index
Clairity
clairity.com·scored August 23, 2026
21/38
Invisible
The page is doing some work, but the story isn't landing fast enough. Buyers and AI are both left guessing what makes Clairity different.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for AI-powered breast cancer risk assessment software for health systems, it named:
Buyer we put in the prompt: Radiologist, breast imaging director, or VP of clinical services at a US health system or hospital network. Both the buyer and the category were inferred from Clairity’s homepage alone. The model had no web access.
Clairity was not on the list.
A buyer who asked AI this question got 8 names and moved on. Clairity never came up.
We asked AI who it recommends for "Radiologist, breast imaging director, or VP of clinical services at a US health system or hospital network" looking for "AI-powered breast cancer risk assessment software for health systems". It named iCAD, Hologic (Genius AI), Volpara Health, Lunit, Seno Medical. You did not appear. AI can't recommend what it can't clearly understand.
Overall assessment
Clairity's biggest strength is its solution clarity ... the hero delivers a specific, mechanistic, FDA-authorized claim an AI or human buyer can repeat verbatim in one sentence. The biggest gap is the complete absence of quantitative proof and cost-of-inaction framing: there are no outcome numbers, no named health system customers, no articulation of what happens to women or providers who don't adopt the tool, leaving the page emotionally inert and commercially thin despite a strong clinical foundation.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
07Cost of Inaction
“No mention of missed diagnoses, delayed interventions, women harmed by current screening gaps, or cost of status quo anywhere on the page.”
The page never names the price a woman or health system pays for not acting ... no stakes, no urgency, no cost of inaction articulated.
All 19 signals, scored 0 to 2.
Total 21/38
Narrative Clarity
8 signals
- 2
01The 7-Second Test
“Clairity Breast is the first FDA-authorized AI platform that predicts a woman's five-year future risk of developing breast cancer, using only her existing screening mammogram.”
Within seconds a stranger knows who it's for (women/health systems), what it does (predicts 5-year breast cancer risk), and the mechanism (existing mammogram only) ... passes the caveman test.
- 1
02Rebellion / Movement
“For more than 60 years, mammograms have saved lives by detecting early-stage cancers. Now, advancements in AI and computer vision can uncover hidden clues”
There's an implicit 'old way vs. new way' framing (detection vs. prediction) but no named enemy, no called-out industry failure pattern, and no manifesto-style rebellion.
- 1
03Owned Language & Category
“Clairity Breast is the first FDA-authorized AI platform that predicts a woman's five-year future risk”
The product name 'Clairity Breast' is specific, and 'five-year future risk' is a concrete frame, but the page doesn't coin a proprietary category name or owned framework an AI could uniquely cite back.
- 1
04ICP Clarity
“Are you a: Patient / Provider or Health System”
The waitlist form reveals two audiences (patients and providers/health systems) but the hero copy never explicitly calls out role, org size, or buying stage for the B2B buyer.
- 1
05Problem Leadership
“Peace of Mind Starts with Understanding Your Risk”
The headline gestures at an emotional problem (lack of peace of mind, unknown risk) but leads with solution branding immediately after, never dwelling on the buyer's pain in their own language.
- 2
06Solution Clarity
“predicts a woman's five-year future risk of developing breast cancer, using only her existing screening mammogram”
A visitor can repeat exactly what the product does in one sentence after reading the hero ... the mechanism and outcome are unambiguous.
- 0
07Cost of Inactionweakest
“No mention of missed diagnoses, delayed interventions, women harmed by current screening gaps, or cost of status quo anywhere on the page.”
The page never names the price a woman or health system pays for not acting ... no stakes, no urgency, no cost of inaction articulated.
- 1
08Promised Land
“help expand access to life-saving early detection and prevention for women everywhere”
The promised land is gestured at (expanded access, life-saving prevention) but remains vague and generic rather than painting a specific, vivid 'after' state for the buyer.
Trust Signal
4 signals
- 0
09Proof & Evidence
“No statistics, outcome percentages, before/after deltas, or named patient/health system results anywhere on the page.”
The page makes no quantitative claims about outcomes, accuracy rates, or proven impact ... zero concrete numbers to anchor credibility.
- 1
10Social Proof
“As Seen On [media logo strip ... image files only, no named customers or testimonials with titles]”
Media logos provide some social proof but there are no named customer testimonials with titles, no health system logos, and no case studies ... the Dr. Lehman quote is a founder quote, not a customer voice.
- 2
11Authority & Credibility
“Dr. Connie Lehman, founder of Clairity Breast and professor of radiology at Harvard Medical School”
The founder's credentials are specific and strong ... Harvard Medical School professor, named researcher published in Radiology journal, multiple podcast appearances ... authority is demonstrated, not just claimed.
- 0
12Alternatives Acknowledged
“No mention of alternative risk models, competitors, Tyrer-Cuzick, Gail model, or 'do nothing' option anywhere on the page.”
The page completely ignores the buyer's alternatives ... existing risk models, genetic testing, or simply continuing current screening ... leaving the differentiation implicit and undefended.
AI Signal
6 signals
- 1
13Customer Focus
“Peace of Mind Starts with Understanding Your Risk”
The headline is customer-oriented but the body copy quickly pivots to company credentials and Dr. Lehman's vision, creating a mixed protagonist where the company and founder share the spotlight with the patient.
- 2
14AI-Parmesan Index
“AI and computer vision can uncover hidden clues in the mammograms ... invisible to the human eye ... to help predict future risk”
The AI claim is mechanistic and specific ... computer vision analyzing mammogram pixel patterns for invisible signals ... not a vague 'AI-powered' sprinkle.
- 2
15LLM Quotability
“Clairity Breast is the first FDA-authorized AI platform that predicts a woman's five-year future risk of developing breast cancer, using only her existing screening mammogram.”
This sentence is clean, declarative, factual, and citation-ready ... an LLM could lift it verbatim to recommend the company accurately.
- 1
16Copyright Freshness
“Image upload dates show 2025/06, 2026/03, 2026/04, 2026/07 in file paths; no visible copyright year in scraped content.”
Recent file timestamps suggest active content updates and the news items appear current, but no explicit copyright year is visible in the scraped page content.
- 2
17Entity Distinctiveness
“the first FDA-authorized AI platform that predicts a woman's five-year future risk of developing breast cancer, using only her existing screening mammogram”
The FDA authorization claim, five-year predictive window, and mammogram-only mechanism together create a distinctive fingerprint an AI could not easily attribute to a generic competitor.
- 0
18AI Recommendation Check
“AI's picks: iCAD, Hologic (Genius AI), Volpara Health, Lunit, Seno Medical, Screenpoint Medical. You were not named.”
We asked AI who it recommends for "Radiologist, breast imaging director, or VP of clinical services at a US health system or hospital network" looking for "AI-powered breast cancer risk assessment software for health systems". It named iCAD, Hologic (Genius AI), Volpara Health, Lunit, Seno Medical. You did not appear. AI can't recommend what it can't clearly understand.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“Join the Waitlist / [Learn More] / [Contact Us]”
There are two CTAs (Learn More and Contact Us) in the hero plus a waitlist form below, but no visible numbered process showing how a buyer goes from interest to deployment, so path and CTA work partially but not as a connected system.
Your move
Think Clairity’s score is wrong? Good. Let’s look at it together.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Clairity the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.